High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$6.2M
$6,161,423
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
MLYS
S
Mineralys Therapeutics, Inc.
Levy Adam Scott
• CFO
10b5-1 SellΔOwn -55.5%
2026-01-12
$345,723
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
10b5-1 SellΔOwn -55.5%
|
2026-01-12 | $345,723 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Other
|
2025-11-11 | $1,490,434Largex4 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Levy Adam Scott
• CFO
Discretionary Sell
2025-11-11
$5,363,716Whalex9
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
Discretionary Sell
|
2025-11-11 | $5,363,716Whalex9 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-10-13 | $451,984x2 | S | Form 4 |